Concepedia

Disha Awasthy

DA

Statistics

Publications

18

Citations

930

H-Index

17

Active since

2009

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

Harvard University

École Polytechnique Fédérale de Lausanne

Disha Awasthy is an author at AstraZeneca (India) specializing in mycobacterium tuberculosis infection, medicinal chemistry, and drug discovery.

Publications per year

2009–2021

18

Publications

18

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i>

Pravin S. Shirude, Radha Krishan Shandil, C Sadler et al. · Journal of Medicinal Chemistry · 2013 · 162 citations

, , +14

4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity

Maruti Naik, Vaishali Humnabadkar, Subramanyam J. Tantry et al. · Journal of Medicinal Chemistry · 2014 · 94 citations · Full text

, , +16

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

Shahul Hameed P, Suresh Solapure, Vikas Patil et al. · Nature Communications · 2015 · 76 citations · Full text

, , +17

Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice

Disha Awasthy, Sheshagiri Gaonkar, Radha Krishan Shandil et al. · Microbiology · 2009 · 61 citations

, , +10

Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase

Sudhir Landge, Amrita B. Mullick, Kavitha Nagalapur et al. · Bioorganic & Medicinal Chemistry · 2015 · 60 citations · Full text

, , +15

1–5 of 18